Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism 
Gold Prices Surge on U.S.-Iran Ceasefire Reports 
China Opens Door to Stronger U.S. Trade Ties Amid Rising Tensions 
ECB Eyes Rate Hike Amid Iran Conflict-Driven Energy Price Surge 
Oil Prices Plunge Over 6% as Middle East Ceasefire Hopes Ease Supply Fears 
Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward 
Australia's Inflation Eases in February but Core Pressures Persist 
Oil Prices Slip as Middle East Tensions Ease, Heading for Weekly Loss 
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis 
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds 
Wall Street Slides as Iran War Uncertainty, Oil Surge, and AI Fears Rattle Markets 
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions 
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions 
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war? 
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty 
U.S. Stock Futures Steady as Iran Reviews U.S. Ceasefire Proposal 
U.S. Oil Prices Slide as Middle East Ceasefire Talks Spark Market Optimism 
China’s WuXi AppTec has signed an agreement to sell its gene therapy manufacturing arm, WuXi Advanced Therapies, to U.S.-based Altaris LLC, following mounting restrictions on Chinese firms in the United States over national security concerns. The deal also includes Oxford Genetics in the UK.
WuXi AppTec Sells Gene Therapy Unit Amid US Restrictions
The Chinese company WuXi AppTec announced on Tuesday that its subsidiaries have inked a contract with the private equity firm Altaris LLC, which is based in the United States, for the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, for an amount that has not been disclosed.
Due to worries regarding national security, the corporation, along with other Chinese businesses, has been at the focus of new regulations that have been enacted in the United States with the intention of restricting their businesses in the United States, Investing.com shares.
US Legislation Targets Chinese Companies Over National Security Concerns
In September, the House of Representatives of the United States of America enacted a bill that would bar the federal government from entering into contracts with specified companies and those that do business with those companies.
The laws are intended to protect the personal health and genetic information of Americans from foreign adversaries.
Shift in US Pharma and Biotech Supply Chains
Additionally, they intend to encourage pharmaceutical and biotechnology businesses in the United States to reduce their reliance on China for a variety of activities, including the manufacturing of medicinal ingredients and early research.
The United Kingdom-based operating company of the WuXi ATU business, Oxford Genetics, will be sold to Altaris LLC, according to a statement made by WuXi.
Altaris declined to comment further than the information that was provided, while WuXi AppTec did not react to a request for comment made by Reuters by the company.
